A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

April 30, 2026

Conditions
Dermatomyositis
Interventions
DRUG

GLPG3667

GLPG3667 capsules will be administered per dose and schedule specified in the arm description.

DRUG

Placebo

Placebo matching to GLPG3667 capsules will be administered per schedule specified in the arm description.

Trial Locations (54)

3000

UZ Leuven, Leuven

10000

Polyclinic Bonifarm, Zagreb

Solmed Polyclinic, Zagreb

10117

Charité - Campus Charité Mitte - Klinik für Dermatologie, Venerologie und Allergologie, Berlin

10154

Ospedale San Giovanni Bosco, Torino

11042

Northwell Health, LLC PRIME, Lake Success

11172

Spitalul Clinic 'Sf. Maria' Clinica de Medicina Interna si Reumatologie, Bucharest

12850

Revmatologicky Ustav, Prague

16635

Altoona Center for Clinical Research, P.C., Duncansville

20089

Istituto Clinico Humanitas U.O. Reumatologia, Rozzano

20132

Ospedale San Raffaele U.O. di Medicina Gen. Ind. Immunologico-Clinica, Milan

25123

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili) Medicina Interna, Brescia

28040

Hospital Universitario Fundacion Jimenez Diaz, Madrid

30912

Augusta University, Augusta

32808

Omega Research Orlando, LLC, Orlando

33186

New Access Research and Medical Center, Kendall

39245

Helios Fachklinik Vogelsang-Gommern, Gommern

55121

St. Paul Rheumatology, Eagan

56100

Azienda Ospedaliero Universitaria Pisana U.O. Reumatologia Universitaria, Pisa

67091

CHU Strasbourg - Hôpital Hautepierre service de rhumatologie, Strasbourg

72076

Universitätsklinikum Tübingen - Universitäts-Hautklinik, Tübingen

75651

Groupe Hospitalier Pitie-Salpetriere service de médecine interne et immunologie cliniqu, Paris

78213

Centro de Alta Especialidad en Reumatología e Investigación del Potosí S.C., San Luis Potosí City

80020

Centro de Investigacion Medico Asistencial S.A.S, Barranquilla

85251

HonorHealth Neurology, Scottsdale

91786

Inland Rheumatology Clinical Trials, Inc., Upland

95100

Azienda Ospedaliero Universitaria Policlinico. PO San Marco, Catania

97070

Medical Care & Research SA de CV, Mérida

240762

Sc Medaudio-Optica SRL, Râmnicu Vâlcea

250252

Healthy Medical Center, Zipaquirá

7500587

Enroll SpA, Santiago

7500710

BioMedica Research Group Psicomedica Clinical and Research Group, Santiago

C1426ABO

Fundacion Respirar Consultorios Médicos Dr. Doreski, Buenos Aires

X5004CDT

Hospital Cordoba, Córdoba

B1900

Hospital Italiano de La Plata, La Plata

B1902

Framingham Centro Medico, La Plata

B1878DVB

Instituto Medico CER, Quilmes

080020

Clinica de la Costa S.A.S, Barranquilla

06001

CHU de Nice Hôpital Pasteur 2 Centre de Réf des Maladies Neuromusculaires et SLA, Nice

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

03720

Centro de Investigacion Clínica GRAMEL S.C, México

07760

Consultorio de Reumatologia Hospital Angeles Lindavista, México

15-707

Nova Reuma Domysławska i Rusiłowicz, Spółka Partnerska Lekarza Reumatologa i Fizjoterapeuty, Bialystok

30-363

Centrum Medyczne Plejady, Krakow

20-582

Zespol Poradni Specjalistycznych Reumed, Lublin

02-953

Klinika Ambroziak ESTEDERM, Warsaw

020125

Spitalul Clinic Colentina parent, Bucharest

08035

Hospital Universitari Vall d'Hebron Internal Medicine Dept., Barcelona

08036

Hospital Clinic de Barcelona Servicio de Medicina Interna, Barcelona

08907

Hospital Universitari de Bellvitge Servicio de Cardiologia, L'Hospitalet de Llobregat

KT16 OPZ

St. Peter´s Hospital Dept of Rheumatology, Chertsey

EH4 2XU

Western General Hospital Dept of Rheumatology, Edinburgh

SE5 9RS

King's College Hospital Dept of Rheumatology, London

M6 8HD

Salford Care Organisation Dept of Rheumatology, Salford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galapagos NV

INDUSTRY